Your trusted source for investing success

Tag: pharmaceutical

Valens GroWorks Appoints President

Valens GroWorks Appoints President

Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“)  is pleased to announce that Mr. Saul Katz has joined the Company as its President.

Mr. Katz brings to Valens 35 years of entrepreneurship, senior management experience and scientific expertise in functional food product development and commercialization. Over his career he established research collaborations with leading

National Research Council and Lexaria Bioscience Commence Laboratory Work

National Research Council and Lexaria Bioscience Commence Laboratory Work

Lexaria Bioscience Corporation (CSE:LXX,OTCQB:LXRP) announces the start of laboratory work under its collaborative research program with the National Research Council of Canada (“NRC”), following the completion of preparation initiatives announced on March 14, 2017.

As earlier reported, several studies will be initiated in the coming months designed to optimize Lexaria’s patented technology

Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution

Isodiol International Inc. signs definitive licensing agreement with Canopy Growth Corporation for Canadian and international distribution

Isodiol International Inc. (CSE: ISOL) (OTC: LAGBF) (Frankfurt: LB6A.F) (the “Company” or “Isodiol”) a global cannabis innovator specializing in the development of pharmaceutical and consumer products is pleased to announce it has signed a licensing agreement with Canopy Growth Corporation (“Canopy”) (TSX:WEED).  

Canopy Growth is the world’s premier cannabis company that

Canadian Marijuana Stocks

Canadian Marijuana Stocks

The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.

Isodiol International Inc. Announces Corporate Update

Isodiol International Inc. Announces Corporate Update

Isodiol International Inc. (CSE:ISOL) (OTC: LAGBF) (FSE: LB6A.F) a global cannabis innovator specializing in the development of pharmaceutical and consumer products, today released its unaudited consolidated sales figures for the month of June 2017. The company recorded sales of $1,843,173 CAD for the thirty-day period ended June 30, 2017.  Total

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network